← Back to Search

Collaborative Care for Opioid Addiction and Mental Health (CHAMP Trial)

N/A
Waitlist Available
Led By John Fortney, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

This trial is testing if a Collaborative Care model can treat opioid use disorder and mental health disorders together in primary care.

Who is the study for?
This trial is for individuals who use opioids and have mental health issues like depression, anxiety, or PTSD. They must show signs of opioid addiction and have experienced symptoms recently. It's not specified who can't join the trial.Check my eligibility
What is being tested?
The study tests if Collaborative Care (CoCM) can treat both mental health disorders and opioid use disorder in primary care settings. One group gets CoCM for both conditions; the control group only for mental health. The outcomes will be compared using different trial designs.See study design
What are the potential side effects?
Since this trial focuses on a care model rather than a specific medication, side effects are related to how effective the treatment is at managing patients' opioid use disorder and mental health conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Mental Health Functioning
Illicit Opioid Use
Secondary outcome measures
Change in Anxiety Symptoms
Change in Depression Symptoms
Change in PTSD Symptoms
+1 more
Other outcome measures
Change in Access to Addiction Care for Opioid Use Disorder
Risk factors for premature mortality

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Collaborative Care for Opioid Use DisorderExperimental Treatment2 Interventions
Collaborative Care Management is an integrated care model that operationalizes the principles of the chronic care model to improve access to evidence-based treatments for opioid use disorder.
Group II: Collaborative Care for Mental Health DisordersActive Control1 Intervention
Collaborative Care Management is an integrated care model that operationalizes the principles of the chronic care model to improve access to evidence-based treatments for mental health disorders.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,762 Previous Clinical Trials
1,875,282 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,820 Previous Clinical Trials
2,691,619 Total Patients Enrolled
University of ArkansasOTHER
488 Previous Clinical Trials
149,269 Total Patients Enrolled

Media Library

Collaborative Care Clinical Trial Eligibility Overview. Trial Name: NCT04600414 — N/A
Opioid Use Disorder Research Study Groups: Collaborative Care for Mental Health Disorders, Collaborative Care for Opioid Use Disorder
Opioid Use Disorder Clinical Trial 2023: Collaborative Care Highlights & Side Effects. Trial Name: NCT04600414 — N/A
Collaborative Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04600414 — N/A
~257 spots leftby Jul 2025